Citations

Clear

6728 citation(s) found for "Li, Mark".

Lower Extremity Neuropathies Associated with Lithotomy Positions
Warner, Mark A. , Harper, C. Michel , Schroeder, Darrell R. , Maxson, Pamela M., Warner, David O. , Schroeder, Darrell

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 93 | Issue: 4 | Pages: 938-942

10.1097/00000542-200010000-00010 | PMID 11020742 Get It

Background The goal of this project was to study the frequency and natural history of perioperative lower extremity neuropathies. Methods A prospective evaluation of lower extremity neuropathies in 991 adult patients undergoing general anesthetics and surgical procedures while positioned in lithotomy was performed. Patients were assessed with use of a standard questionnaire and neurologic examination before surgery, daily during hospital stay in the first week after surgery, and by phone if discharged before 1 postoperative week. Patients in whom lower extremity neuropathies developed were observed for 6 months. Results Lower extremity neuropathies developed in 15 patients (1.5%; 95% confidence interval, 0.8-2.5%). Unilateral or bilateral nerves were affected in patients as follows: obturator (five patients), lateral femoral cutaneous (four patients), sciatic (three patients), and peroneal (three patients). Paresthesia occurred in 14 of 15 patients, and 4 patients had burning or aching pain. No patient had weakness. Symptoms were noted within 4 h of completion of the anesthetic in all 15 patients. These symptoms resolved within 6 months in 14 of 15 patients. Prolonged positioning in a lithotomy position, especially for more than 2 h, was a major risk factor for this complication (P = 0.006). Conclusions In this surgical population, lower extremity neuropathies were infrequent complications that were noted very soon after surgery and anesthesia. None resulted in prolonged disability. The longer patients were positioned in lithotomy positions, the greater the chance of development of a neuropathy. These findings suggest that a reduction of duration of time in lithotomy positions may reduce the risk of lower extremity neuropathies.
Book Reviews
Olsen, Mark W.

Mayo Clinic

Clinical Child Psychology and Psychiatry | November 3, 2003 | Volume: 6 | Issue: 1 | Pages: 182-183

10.1177/1359104501006001028 Get It

Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes
Santas, Amy J. , Bahler, Cindy K., Peterson, Jennifer A., Filla, Mark S. , Kaufman, Paul L., Tamm, Ernst R. , Peters, Donna M. , Johnson, Douglas H.

Mayo Clinic

Investigative Opthalmology & Visual Science | October 24, 2003 | Volume: 44 | Issue: 11 | Pages: 4796

10.1167/iovs.02-1083 | PMID 14578401 Get It

Resource Utilization and Procedure Parameters for the Stretta Procedure: Comparison with Endoscopic Ultrasonography and Colonoscopy
Wolfsen, Herbert C. , Hemminger, Lois L., Stark, Mark E., Achem, Sami R., Loeb, David S. , Woodward, Timothy A., DeVault, Kenneth R.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | October 8, 2003 | Volume: 13 | Issue: 5 | Pages: 291-294

10.1089/109264203769681646 | PMID 14617384 Get It

PNAs for AML
Litzow, Mark R.

Mayo Clinic

Blood | September 22, 2003 | Volume: 102 | Issue: 7 | Pages: 2315-2315

10.1182/blood-2003-07-2515 Get It

Localization and Regulation of Pregnancy-Associated Plasma Protein A Expression in Healing Human Skin
Chen, Bingkun , Leiferman, Kristin M. , Pittelkow, Mark R. , Overgaard, Michael T. , Conover, Cheryl A. , Oxvig, Claus

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | September 12, 2003 | Volume: 88 | Issue: 9 | Pages: 4465-4471

10.1210/jc.2003-030193 | PMID 12970325 Get It

Pregnancy-associated plasma protein A (PAPP-A) is an IGF-binding protein-4 (IGFBP-4) metalloproteinase that cleaves inhibitory IGFBP-4 to amplify local IGF-I bioavailability in vitro. Thus it has functional implications in injury/repair responses. In this study we determined PAPP-A expression in healing human skin. Wounds were induced with a scalpel on the forearms of three normal subjects and were allowed to heal by first intention. Biopsies obtained on d 0, 2, 8, and 14 were processed for immunohistochemical detection of PAPP-A, IGF-I, and IGFBP-4. In uninjured skin (d 0), strong staining for PAPP-A was present in the epidermis, sweat and sebaceous gland epithelial cells, hair follicles, and blood vessels; no PAPP-A was detected in dermal fibroblasts or with mature collagen bundles. IGF-I localized strongly to epithelial cells of skin glands was weak to moderate in epidermis and blood vessels, and was absent in dermal cells. Weak focal staining for IGFBP-4 was found within uninjured epidermis. During wound healing, PAPP-A expression was induced in dermal granulation tissue within and adjacent to the injury. PAPP-A was present in dermis on d 2 and was increased in intensity and extent on d 8 and 14. PAPP-A expression also increased in the epidermis. PAPP-A expression in cells of granulation tissue colocalized with α-smooth actin staining of myofibroblasts and new blood vessels as well as with CD68 staining of macrophages and was associated with the compact, newly synthesized collagen of the healing wound. IGF-I staining was enhanced in the epidermis localized to the area of the incision and in granulation tissue associated with lymphoid cells. IGFBP-4 staining of the epidermis remained unchanged during wound healing, but was induced in the fibroblastic cells of granulation tissue over time. These data demonstrate localized and regulated expression of PAPP-A in human skin and suggest that PAPP-A may play an important role in an integrated IGF system in wound healing and tissue remodeling in vivo.
Evolutionary Pressure of a Receptor Competitor Selects Different Subgroup A Avian Leukosis Virus Escape Variants with Altered Receptor Interactions
Melder, Deborah C., Federspiel, Mark J. , Pankratz, V. Shane

Mayo Clinic

Journal of Virology | September 11, 2003 | Volume: 77 | Issue: 19 | Pages: 10504-10514

10.1128/jvi.77.19.10504-10514.2003 | PMID 12970435 Get It

ABSTRACT A complex interaction between the retroviral envelope glycoproteins and a specific cell surface protein initiates viral entry into cells. The avian leukosis-sarcoma virus (ALV) group of retroviruses provides a useful experimental system for studying the retroviral entry process and the evolution of receptor usage. In this study, we demonstrate that evolutionary pressure on subgroup A ALV [ALV(A)] entry exerted by the presence of a competitive inhibitor, a soluble form of the ALV(A) Tva receptor linked to a mouse immunoglobulin G tag (quail sTva-mIgG), can select different populations of escape variants. This escape population contained three abundant ALV(A) variant viruses, all with mutations in the surface glycoprotein hypervariable regions: a previously identified variant containing the Y142N mutation in the hr1 region; a new variant with two mutations, W141G in hr1 and K261E in vr3; and another new variant with two mutations, W145R in hr1 and K261E. The W141G K261E and W145R K261E viruses escape primarily by lowering their binding affinities for the quail Tva receptor competitive inhibitor while retaining wild-type levels of binding affinity for the chicken Tva receptor. A secondary phenotype of the new variants was an alteration in receptor interference patterns from that of wild-type ALV(A), indicating that the mutant glycoproteins are possibly interacting with other cellular proteins. One result of these altered interactions was that the variants caused a transient period of cytotoxicity. We could also directly demonstrate that the W141G K261E variant glycoproteins bound significant levels of a soluble form of the Tvb S3 ALV receptor in a binding assay. Alterations in the normally extreme specificity of the ALV(A) glycoproteins for Tva may represent an evolutionary first step toward expanding viral receptor usage in response to inefficient viral entry.
The Mitochondrial Protein hFis1 Regulates Mitochondrial Fission in Mammalian Cells through an Interaction with the Dynamin-Like Protein DLP1
Yoon, Yisang , Krueger, Eugene W. , Oswald, Barbara, McNiven, Mark A.

Mayo Clinic

Molecular and Cellular Biology | July 14, 2003 | Volume: 23 | Issue: 15 | Pages: 5409-5420

10.1128/mcb.23.15.5409-5420.2003 | PMID 12861026 Get It

Clinical Diagnosis of Hypersensitivity Pneumonitis
Lacasse, Yves , Selman, Moisés , Costabel, Ulrich , Dalphin, Jean‐Charles, Ando, Masayuki, Morell, Ferrán , Erkinjuntti‐Pekkanen, R., Müller, Néstor L. , Colby, Thomas V. , Schuyler, Mark, Cormier, Yvon

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | July 7, 2003 | Volume: 168 | Issue: 8 | Pages: 952-958

10.1164/rccm.200301-137oc | PMID 12842854 Get It

Abstract The diagnosis of hypersensitivity pneumonitis (HP) is difficult and often relies on histopathology. Our objective was to identify diagnostic criteria and to develop a clinical prediction rule for this disease. Consecutive patients presenting a condition for which HP was considered in the differential diagnosis underwent a program of simple standardized diagnostic procedures. High-resolution computed tomography scan and bronchoalveolar lavage (BAL) defined the presence or absence of HP. Patients underwent surgical lung biopsy when the computed tomography scan, BAL, and other diagnostic procedures failed to yield a diagnosis. A cohort of 400 patients (116 with HP, 284 control subjects) provided data for the rule derivation. Six significant predictors of HP were identified: (1) exposure to a known offending antigen, (2) positive precipitating antibodies to the offending antigen, (3) recurrent episodes of symptoms, (4) inspiratory crackles on physical examination, (5) symptoms occurring 4 to 8 hours after exposure, (6) and weight loss. The area under the receiver operating characteristic curve was 0.93 (95% confidence interval: 0.90–0.95). The rule retained its accuracy when validated in a separate cohort of 261 patients. The diagnosis of HP can often be made or rejected with confidence, especially in areas of high or low prevalence, respectively, without BAL or biopsy.